Source: Global Legal Chronicle

Highland Capital Management: Caris Life Sciences' $830 Million Growth Equity Round

Shearman & Sterling represented Caris Life Sciences Inc. in the transaction. Caris Life Sciences Inc. executed an $830 million growth equity round. As a result of [...]

Read full article »
Highland Capital Management's Competitors | Highland Capital Management's News | Highland Capital Management's Financials
Stay up-to-date with the latest news on Highland Capital Management
Est. Annual Revenue
$25-100M
Est. Employees
100-250
James Dondero's photo - President of Highland Capital Management

President

James Dondero

CEO Approval Rating

85/100

Read more
Stay up-to-date with the latest news on Highland Capital Management